71 research outputs found

    Antidiarrhoeal activity of Ziziphus mauritiana root extract in rodents

    Get PDF
    Preliminary phytochemical screening of the root extract of Ziziphus mauritiana revealed the presence of alkaloids, flavonoids, glycosides, saponins and volatile oil. Intraperitoneal LD50 of the extract was found to be 447.21 ± 20 mg/kg (bw) in mice. The Antidiarrhoeal effect of the methanolic extract as evaluated exhibited a concentration dependent inhibition of the spontaneous pendular movement of the isolated rabbit jejunum and inhibited acetylcholine induced contraction of rat ileum. A dose dependent decrease of gastrointestinal transit was observed with extracts (25 and 50 mg/kg) which also protected mice against castor oil induced dirrhoea and castor oil induced fluid accumulation, respectively. The presence of some of the phytochemicals in the root extract may be responsible for the observed effects, and also the basis for its use in traditional medicine as antidiarrhoeal dru

    Effect of Information Disclosure on Compliance with CAMA 2004 of Listed Telecommunication Companies in Nigeria

    Get PDF
    Compliance with regulatory requirements has increasingly become a concern of corporate and public sector management. However, little is known about why some companies are not complying with CAMA in Nigeria. The objective of this study is to examine the effect of information disclosure on compliance with CAMA 2004 of listed telecommunication companies in Nigeria.  The study adopted ex-post facto research design using secondary data.  The data was collected from the financial statements of four telecommunication companies for the period of 2011 to 2015. The multiple regression statistics was used to analyze the data. The finding reveals that the compliance index computed indicates that the telecommunication fully complied with CAMA.  Furthermore, the attributes (MID and VID) have positive correlation with compliance with CAMA. It is concluded that, it is not only compliance with accounting standards, but also compliance with the legal statutes such as CAMA for users of accounting information to obtain quality information for their various users decision- making. It is therefore recommended that NCC should monitor the compliance with the requirements of information disclosure and pursue its objective to achieve best corporate governance practice in telecommunication. Keywords: Compliance; CAMA; Information disclosure; Telecommunication companies; Nigeri

    Driving better programme investment and accelerating challenge impact through a prioritisation matrix of international and national perspectives

    Get PDF
    This report presents the first stage of an overview of international and national drivers which have the potential to affect land use change and/or practice. The report is structured as follows; Chapter 1 will give an introduction and is followed by the methodology for quantifying the importance of these drivers in Chapter 2. Collation and valuation of drivers are described in Chapter 3, followed by scenario analysis to explore different futures in Chapter 4. The report finishes with suggestions for future research in Chapter 5

    RABIES IN A SET OF EIGHT-WEEK OLD PUPPIES IN NIGERIA: THE NEED FOR REVIEW OF CURRENT DOG ANTIRABIES VACCINATION SCHEDULE

    Get PDF
    Background: Rabies is endemic in Nigeria with clinical cases reported mainly in dogs and occasionally in livestock from all the geo-ecological zones of the country. Detection of rabies virus antigen in puppies at the age of five to ten weeks and in apparently healthy dogs shedding the virus in their saliva have been reported in some parts of Nigeria. Material and Method: This report describes a clinical rabies in a set of eight weeks old puppies confirmed by antigen detection using the direct fluorescent antibody test (DFAT), the direct rapid immunohistochemical test (DRIT), and RT-PCR. Results: it was positive for all test used including the RT-PCR which amplified at 750 bp from the gel electrophoresis. Conclusion: Occurrence of rabies in puppies of this age, within which they are acquired and owned by other unsuspecting members of the public, is of grave public health consequences. People that love puppies, especially children, who are fond of carrying and playing with them, are also faced with the risk of exposure to rabies. Consequently, review of the existing dog antirabies vaccination schedule at twelve weeks of age in Nigeria, is recommended to ensure effective immunization of this age group of dogs and for the overall safety of the vulnerable members of the public

    Marine mammals and Good Environmental Status: Science, Policy and Society; Challenges and Opportunities

    Get PDF
    The Marine Strategy Framework Directive has become the key instrument for marine conservation in European seas. We review its implementation, focusing on cetacean biodiversity, using the examples of Spain and the Regional Seas Convention, OSPAR. The MSFD has been widely criticised for legal vagueness, lack of coordination, uncertainty about funding, and poor governance; its future role within EU Integrated Maritime Policy remains unclear. Nevertheless, the first stages of the process have run broadly to schedule: current status, environmental objectives and indicators have been described and the design of monitoring programmes is in progress, drawing on experience with other environmental legislation. The MSFD is now entering its critical phase, with lack of funding for monitoring, limited scope for management interventions, and uncertainty about how conservation objectives will be reconciled with the needs of other marine and maritime sectors, being among the main concerns. Clarity in governance, about the roles of the EU, Member States, Regional Seas Conventions and stakeholders, is needed to ensure success. However, even if (as seems likely) good environmental status cannot be achieved by 2020, significant steps will have been taken to place environmental sustainability centre-stage in the development of Integrated Maritime Policy for EU seas.Postprin

    Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

    Get PDF
    BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years
    corecore